drugset / Trial / NCT05801757

Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients

NCT05801757

Completed 114 enrolled Tongji Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

To observe the sedative effect of continuous infusion of remidazolam in elderly patients undergoing colonoscopic polypectomy.

Timeline

Start
2023-05-01
Primary completion
2024-04-30
Completion
2024-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 2 mg/kg
Subject Remimazolam Small molecule 0.5 mg/kg
Subject Remimazolam Small molecule 0.75 mg/kg

Indications